PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy

BACKGROUND: Intravascular large B‐cell lymphoma (IVLBCL) is a rare form of diffuse large B‐cell lymphoma (DLBCL) arising in extranodal sites. PD‐L1 expression of tumor cells has been reported in IVLBCL cells, but its clinicopathological relevance remains to be elucidated. AIMS: This study was aimed...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Med
Egile Nagusiak: Suzuki, Yuka, Kohno, Kei, Matsue, Kosei, Sakakibara, Ayako, Ishikawa, Eri, Shimada, Satoko, Shimada, Kazuyuki, Mabuchi, Seiyo, Takahara, Taishi, Kato, Seiichi, Nakamura, Shigeo, Satou, Akira
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Cancer Biology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333862/
https://ncbi.nlm.nih.gov/pubmed/32367674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3104
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak